MPXOF - MPX International Corporation

Other OTC - Other OTC Delayed Price. Currency in USD
0.3605
-0.0076 (-2.06%)
At close: 3:33PM EDT
Stock chart is not supported by your current browser
Previous Close0.3681
Open0.3600
Bid0.0000 x 0
Ask0.0000 x 0
Day's Range0.3101 - 0.3800
52 Week Range0.2253 - 0.6358
Volume25,729
Avg. Volume42,456
Market Cap46.995M
Beta (3Y Monthly)N/A
PE Ratio (TTM)N/A
EPS (TTM)N/A
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • PR Newswire

    Cannabis Virtual Investor Conference Presentations Now Available for On-Demand Viewing

    Individual and institutional investors as well as advisors are invited to log-on to VirtualInvestorConferences.com to view the presentations NEW YORK , Sept. 16, 2019 /PRNewswire/ -- Virtual Investor Conferences ...

  • CNW Group

    /R E P E A T -- Live Investor Conference & Webinar: Cannabis Industry Companies Present September 12th/

    /R E P E A T -- Live Investor Conference & Webinar: Cannabis Industry Companies Present September 12th/

  • PR Newswire

    MPX International to Webcast Live at VirtualInvestorConferences.com Sept. 12th

    Company invites individual and institutional investors, as well as advisors and analysts, to attend real-time, interactive presentations on VirtualInvestorConferences.com TORONTO , Sept. 9, 2019 /PRNewswire/ ...

  • PR Newswire

    Live Investor Conference & Webinar: Cannabis Industry Companies Present September 12th

    Cannabis Company Executives share vision, answer questions live at VirtualInvestorConferences.com NEW YORK , Sept. 6, 2019 /PRNewswire/ -- Virtual Investor Conferences and KCSA Strategic Communications ...

  • CNW Group

    /C O R R E C T I O N from Source -- VirtualInvestorConferences.com/

    /C O R R E C T I O N from Source -- VirtualInvestorConferences.com/

  • ACCESSWIRE

    MPX International Secures Good Manufacturing Practice (GMP) and Quality System Certification for Canveda Manufacturing Facility in Peterborough, Ontario

    OTC PINK:MPXOF) today announced that its wholly-owned subsidiary, Canveda Inc. (“Canveda”) has achieved Gold Status in its bQb-cert Good Manufacturing Practice (“GMP”) and Quality System Compliance Audit at its 12,000 square foot facility located in Peterborough, Ontario, where it produces high quality cannabis flower. Achieving GMP certification demonstrates MPXI’s commitment to quality and safety in cannabis manufacturing and is an important milestone in the Company’s international growth strategy. MPXI is strategically positioned to pursue opportunities in the emerging global cannabis marketplace and plans to use its cannabis assets in Canada as a base to export to targeted international markets.

  • ACCESSWIRE

    MPX International Announces Third Quarter 2019 Financial Results

    TORONTO, ON / ACCESSWIRE / August 28, 2019 / MPX International Corporation (“MPX International”, “MPXI” or the “Company”) (MPXI.CN) (OTC Pink:MPXOF) today reports financial results for its fiscal third quarter for the three and nine month period ended June 30, 2019. All figures are presented in Canadian dollars unless otherwise indicated.

  • ACCESSWIRE

    MPX International Announces Closing of Acquisition of Gmp-Ready Pharmaceutical Facility in Malta

    TORONTO, ON / ACCESSWIRE / August 16, 2019 / MPX International Corporation (“MPX International”, “MPXI” or the “Company”) (MPXI.CN) (OTC Pink:MPXOF) is pleased to announce that MPXI Malta Property Ltd. (“MPXI Malta”), a Maltese-company owned by MPX International (80%) and Malta-based Bortex Group (“Bortex”) (20%) has completed the acquisition of all the outstanding shares of Alphafarma Operations Ltd. (“Alphafarma”) from Alpha Farma Limited (the “Vendor”). The Vendor, which is in the business of acquiring, repackaging and distributing pharmaceutical products throughout the European Union and North Africa, has transferred the lease for the “GMP-ready” facility located in Mehriel, just outside of Valletta, the capital city of Malta, as well as the GMP certification to Alphafarma, the newly created subsidiary of the Vendor, in exchange for the payment of €1.5 million (approximately CDN$2,260,800) in cash and the issuance of 1,000,000 common shares (“MPXI Shares”) and 300,000 common share purchase warrants to acquire additional MPXI Shares at an exercise price of $0.63 per MPXI Share for a period of five (5) years.

  • ACCESSWIRE

    MPX International Adds New Senior Management to Support International Growth

    TORONTO, ONTARIO / ACCESSWIRE / August 6, 2019 / MPX International Corporation (“MPX International”, “MPXI” or the “Company”) (MPXI.CN)(OTC PINK:MPXOF) is pleased to announce that Dr. Amer Cheema and Nicholas Varone are joining the Company as its Vice President, Cultivation and Director of Extraction and Processing, respectively. Dr. Cheema is an award winning and highly motivated professional with a Ph.D. in Plant Physiology and Biochemistry from the University of Guelph, an International Advanced Diploma in Computer Science and Human Resource Management and over 25 years of multidimensional experience and leadership background in new business development in the cannabis industry and a variety of other plant productions.

  • ACCESSWIRE

    MPX International Featured in a BBC Documentary on Canadian Cannabis Policy

    TORONTO, ON / ACCESSWIRE / July 31, 2019 / MPX International Corporation (“MPX International”, “MPXI” or the “Company”) (MPXI.CN)(OTC PINK:MPXOF) is pleased to announce that it was featured in a BBC Documentary “Legalising cannabis: Canada's story” on July 29, 2019. The documentary received wide coverage on global BBC platforms and takes a look at the issues Canada grappled with prior to the legalization of cannabis and the impacts of legalization on the industry, the economy and society. It focuses on a group of UK delegates visiting Canada to see how its experience as the first G7 nation to legalize cannabis is panning out.

  • ACCESSWIRE

    MPX International’s Canveda Inc. Receives Licence Amendment for Sale of Dried/Fresh Cannabis from Health Canada

    OTC:MPXOF) is pleased to announce that Canveda Inc. (“Canveda”), a wholly-owned subsidiary of MPXI, has received approval from Health Canada to sell Cannabis, effective as of July 26, 2019, in accordance with Sections 11(5), 17(5) and 27 of the Cannabis Regulations pursuant to an application to amend the conditions of its previously obtained licence for standard cultivation to allow for the sale of fresh and dried cannabis products. “The ability to sell into both the recreational and medical cannabis markets in Canada as a result of this amendment represents a significant milestone for Canveda and opens the door to significant growth opportunities that we are ready to capitalize on,” said W. Scott Boyes, Chairman, President and CEO of MPX International.

  • ACCESSWIRE

    MPX International Acquires Remaining Interest in MPX Australia

    In addition, the Company will issue 327,123 MPXI Shares at a price of $0.46 per MPXI Share to satisfy the principal as well as the accrued and unpaid interest on a loan incurred by MPX Australia from the lender in the aggregate amount of $152,054.88 (the “Loan Conversion Amount”). MPX Australia has applied to the Australian Office of Drug Control for a medicinal cannabis license (cultivation and production) in Australia in accordance with the Narcotic Drugs Act 1967 (Cth) (the “Cannabis License”) and is in the process of designing a facility in Tasmania, Australia (the “Launceston Facility”).

  • ACCESSWIRE

    MPX International Acquires 20% stake in Medical Cannabis Learning Network

    TORONTO, ON / ACCESSWIRE / July 16, 2019 / MPX International Corporation (“MPX International”, “MPXI” or the “Company”) (CSE: MPXI, OTC PINK: MPXOF) is pleased to announce that it has acquired a 20% stake in 2702148 Ontario Inc. dba KAAJENGA Cannabis (“KAAJENGA Cannabis”) on July 16, 2019, securing the exclusive rights to a turnkey video learning and engagement platform for the Cannabis Industry. This investment positions MPXI at the forefront of compliant patient, doctor and healthcare practitioner education and provides MPXI with a unique mechanism for supporting patient communities. The learning will be delivered through a kiosk that will engage and educate patients and provide a process to fulfill prescriptions for medical cannabis, all in a manner compliant with the Cannabis Act (Canada) (the “Cannabis Act”).

  • Benzinga

    Discussing MPX International's South Africa Joint Venture With CEO Scott Boyes

    MPX International Corp (OTC: MPXOF) recently announced entrance into an agreement with South African producer First Growth Holdings Ltd. that will lead to the acquisition of a 51% interest in the company. Interested in the acquisition and the African market, Benzinga reached out to Scott Boyes, Chairman, President and CEO of MPXI to discuss what makes South Africa so desirable, how their legislation impacts cannabis and where MPXI sees future potential in other African Markets. MPXI chose to launch their new venture and face this risk.

  • ACCESSWIRE

    MPX International Provides Webcast Links for Corporate Update on June 26, 2019

    Company to present live at The Washington Mayfair Hotel, London, during European Cannabis Week NOT FOR DISTRIBUTION TO NEWSWIRE SERVICES IN THE UNITED STATES OR FOR DISSEMINATION IN THE UNITED STATES. ...

  • ACCESSWIRE

    MPX International to Provide Corporate Update

    Presenting on June 26th at The Washington Mayfair Hotel NOT FOR DISTRIBUTION TO NEWSWIRE SERVICES IN THE UNITED STATES OR FOR DISSEMINATION IN THE UNITED STATES. ANY FAILURE TO COMPLY WITH THIS RESTRICTION ...

  • ACCESSWIRE

    MPX International Extends Partnership with Volteface

    OTC PINK: MPXOF) is pleased to announce that it is extending its partnership with Volteface, a UK-based cross party organization that informs the public debate around drugs through excellence in policy, research and advocacy. Since starting out in 2016, with the aim of providing a new focus on drug policy reform, Volteface has evolved into an important and influential organization. During this time, the United Kingdom has seen significant developments in cannabis reform, most notably the legalization of medical cannabis in November 2018.

  • ACCESSWIRE

    MPX International Establishing Cannabis Joint Venture in South Africa

    OTC PINK: MPXOF) is pleased to announce that it has entered into an agreement with First Growth Holdings (Pty) Ltd. ("First Growth") which provides the basis for MPXI and First Growth to enter into a series of agreements through which MPXI intends to acquire a 51% interest in First Growth, subject to the completion of due diligence as well as definitive documentation. First Growth is applying under the Medicines and Related Substances Act, No. 101 of 1965 for a license to cultivate, manufacture and export cannabis from the Sonop Farm, which is located in the traditional wine-growing region of Stellenbosch in South Africa's Western Cape.

  • ACCESSWIRE

    MPX International Strengthens Advisory Board to Guide European Expansion Initiatives

    OTC PINK: MPXOF) is pleased to announce the addition of Dr. Charles Akle to its medical advisory board. The UK-based Dr. Akle is a leading world authority in the fields of immunology and cancer treatment, renowned for over 30 years of pioneering work in clinical surgery and developing products in the biotech industry. "His experience navigating emerging medical markets and working with the various regulatory bodies is unique and invaluable as we look to further develop and introduce our products in a responsible and sustainable manner," said W. Scott Boyes, Chairman, President and CEO of MPXI.

  • ACCESSWIRE

    Premium Swiss Organic CBD Brand HolyWeed Takes First Step into EU Market with Belgium Import Approval

    TORONTO, ONTARIO / ACCESSWIRE / May 23, 2019 / MPX International Corporation ("MPX International", "MPXI" or the "Company") (CSE: MPXI; OTC PINK: MPXOF) is pleased to announce ...

  • Benzinga

    MPX International Finalizes Purchase Of Swiss Cannabis Company HolyWeed

    Global cannabis company MPX International Corp (OTC: MPXOF ) said Tuesday that it had completed the acquisition of Swiss-based HolyWorld SA, which operates under the HolyWeed brand. What Happened MPX International ...

  • ACCESSWIRE

    MPX International Announces Acquisition of GMP-Ready Pharmaceutical Facility in Malta, and Receipt of Letter of Intent From Malta Enterprise for a Cannabis Production License

    OTC PINK: MPXOF) is pleased to announce that MPXI Malta Property Ltd. (''MPXI Malta''), a Maltese-company owned by MPX International (80%) and Malta-based Bortex Group (''Bortex'') (20%) has entered into a definitive agreement to purchase all outstanding shares of Alphafarma Operations Ltd. (''Alphafarma'') from Alpha Farma Limited (the ''Vendor''). Additionally, MPXI Malta has been awarded a letter of intent (the ''LOI'') from Malta Enterprise, the economic development agency for the Republic of Malta, a member of the European Union, to receive a license to import, extract, produce finished products and distribute cannabis and cannabis derivatives (the ''License'') for medicinal use in Malta and export to certain international markets, such as the European Union.

  • ACCESSWIRE

    MPX International Acquires HolyWeed, a Swiss Premium Organic Cannabis Company

    OTC PINK: MPXOF) is pleased to announce that it has entered into a definitive agreement to purchase all outstanding shares of HolyWorld SA ("HolyWeed") from Romain Gruner, Bernard Rappaz and Laurent Rappaport (the "Shareholders"). This acquisition represents a major step in MPXI's expansion strategy, adding a highly recognized brand to its portfolio, as well as one of the largest Western European outdoor cultivators of high-CBD flowers. Pursuant to the terms of the Purchase Agreement, MPXI will acquire all of the HolyWeed Shares for a total purchase price of CHF10,000,000 (CDN$13,384,000 calculated using a deemed exchange rate of CDN$1.34 for each CHF1.00 for the purposes of this resolution which number shall be adjusted upwards or downwards to the extent necessary using the exchange rate posted at the close of business by the Bank of Canada five (5) days prior to closing) through the issuance of common shares of MPXI (the "MPXI Shares") at price of CDN$0.53 per MPXI Share.